Primary |
Constipation |
41.1% |
Drug Use For Unknown Indication |
10.0% |
Product Used For Unknown Indication |
7.8% |
Nutritional Support |
5.6% |
Blood Pressure |
4.4% |
Pain |
4.4% |
Blood Cholesterol |
3.3% |
Ovarian Cancer |
3.3% |
Arthritis |
2.2% |
Diverticulitis |
2.2% |
Haemorrhoids |
2.2% |
Hypertension |
2.2% |
Lymphoma |
2.2% |
Thyroid Disorder |
2.2% |
Asthma |
1.1% |
Bowel Movement Irregularity |
1.1% |
Cerebrovascular Accident Prophylaxis |
1.1% |
Chest Pain |
1.1% |
Chronic Obstructive Pulmonary Disease |
1.1% |
Depression |
1.1% |
|
Vomiting |
18.4% |
Drug Ineffective |
7.9% |
Intestinal Obstruction |
7.9% |
Nausea |
7.9% |
Constipation |
5.3% |
Cystitis |
5.3% |
Megacolon |
5.3% |
Myelodysplastic Syndrome |
5.3% |
Neoplasm Malignant |
5.3% |
Rectal Haemorrhage |
5.3% |
Ageusia |
2.6% |
Colitis |
2.6% |
Death |
2.6% |
Dizziness |
2.6% |
Drug Abuse |
2.6% |
Faecaloma |
2.6% |
Flatulence |
2.6% |
Frequent Bowel Movements |
2.6% |
Gastrointestinal Disorder |
2.6% |
Gastrointestinal Haemorrhage |
2.6% |
|
Secondary |
Drug Use For Unknown Indication |
26.2% |
Product Used For Unknown Indication |
17.0% |
Constipation |
15.1% |
Ovarian Epithelial Cancer |
6.6% |
Type 2 Diabetes Mellitus |
4.4% |
Bowel Preparation |
3.7% |
Hypertension |
3.7% |
Mantle Cell Lymphoma |
3.0% |
Abdominal Pain Upper |
2.2% |
Metastatic Renal Cell Carcinoma |
2.2% |
Cardiac Failure |
1.8% |
Lymphoma |
1.8% |
Pain |
1.8% |
Abdominal Discomfort |
1.5% |
Chronic Obstructive Pulmonary Disease |
1.5% |
Diverticulitis |
1.5% |
Influenza Like Illness |
1.5% |
Lipids |
1.5% |
Osteoarthritis |
1.5% |
Sleep Disorder |
1.5% |
|
Small Intestinal Obstruction |
13.0% |
Vomiting |
13.0% |
Somnolence |
9.3% |
Death |
7.4% |
Convulsion |
5.6% |
Drug Ineffective |
5.6% |
Lymphoma |
5.6% |
Urinary Tract Infection |
5.6% |
Breast Cancer Metastatic |
3.7% |
Constipation |
3.7% |
Diarrhoea |
3.7% |
Medication Error |
3.7% |
Pulmonary Mass |
3.7% |
Umbilical Hernia |
3.7% |
Wrong Drug Administered |
3.7% |
Dehydration |
1.9% |
Diverticulitis |
1.9% |
Fatigue |
1.9% |
Frequent Bowel Movements |
1.9% |
Gastroenteritis |
1.9% |
|
Concomitant |
Product Used For Unknown Indication |
22.7% |
Drug Use For Unknown Indication |
21.6% |
Pain |
8.5% |
Constipation |
8.3% |
Multiple Myeloma |
6.0% |
Hypertension |
4.6% |
Nausea |
4.1% |
Non-small Cell Lung Cancer |
4.0% |
Prophylaxis |
2.9% |
Osteoporosis |
2.1% |
Anxiety |
2.0% |
Gastrooesophageal Reflux Disease |
1.8% |
Depression |
1.8% |
Supplementation Therapy |
1.5% |
Insomnia |
1.5% |
Rheumatoid Arthritis |
1.5% |
Premedication |
1.4% |
Breast Cancer |
1.4% |
Diabetes Mellitus |
1.2% |
Diffuse Large B-cell Lymphoma |
1.1% |
|
Vomiting |
16.3% |
Weight Decreased |
10.5% |
Pneumonia |
7.7% |
Urinary Tract Infection |
7.3% |
Death |
7.1% |
Pulmonary Embolism |
5.9% |
White Blood Cell Count Decreased |
4.3% |
Pyrexia |
4.2% |
Weight Increased |
4.2% |
Sepsis |
4.1% |
Thrombocytopenia |
3.8% |
Syncope |
3.2% |
Nausea |
3.2% |
Renal Failure Acute |
3.2% |
Respiratory Failure |
2.8% |
Tremor |
2.8% |
Dyspnoea |
2.7% |
Pain |
2.4% |
Pleural Effusion |
2.2% |
Wheezing |
2.2% |
|
Interacting |
Acute Myeloid Leukaemia |
100.0% |
|
Neutropenia |
50.0% |
Vomiting |
50.0% |
|